PhorMed

PhorMed is a clinical stage biotech company focused on developing treatments in oncology, neuroscience and inflammation using cell repair therapy.

[PhorMed @Phormed1]

Unlocking biotech potential with cellular restoration 📷📷 Join us in our mission at https://t.co/oULMwjw3lm #Phormed to redefine medical breakthroughs. #CrowdfundingForChange #InvestInInnovation #invest #crowdfunding #Biotechnology

[PhorMed @Phormed1]

Invest now link in bio! Invest in the future of medicine. #Biotechnology #invest #investnow #crowdfunding #Parkinsonsdisease #CancerResearch #clinicaltrials #STEM #Startup

[PhorMed @Phormed1]

Invest in PhoMed today, an SEC regulated campaign, link in bio. #biotech #invest #investnow #crowdfunding #parkinsons #cancerresearch #clinicaltrials #stem #startup #fypage

[PhorMed @Phormed1]

Invest now in bio! Invest in PhorMed’s pharmaceutical research, backed by the SEC. #invest #biotech #stem #crowdfunding #startup #antiinflammatory

[PhorMed @Phormed1]

Invest now in bio! Invest in PhorMed’s biotechnology for medical treatments of the future. #invest #biotech #crowdfunding #pharma #investnow

[PhorMed @Phormed1]

PhorMed published a Press Release, announcing discovery that their study drug works on ARDS, a lung disorder caused by COVID-19 amongst other causes. and are now in the process of filing a Phase 2 human clinical trial to treat ARDS. Click https://t.co/4hSmjxNAya for more info

[PhorMed @Phormed1]

PhorMed is paving the way in the field of genomic medicine.

Learn more at https://t.co/1lkjkmyUdK and look for time-based information today!

#cancer #biotech #biotechnology

[PhorMed @Phormed1]

Please take a moment to visit our webpage at https://t.co/OoivsaXzHB to find out more about our technology and take advantage of time-based rewards #biotech #Cancer #investment #oncology #Neurology

[PhorMed @Phormed1]

PhorMed is excited to announce the launch of our second StartEngine campaign! Our last campaign close was very successful thanks to all our Investors. We are looking forward to an exciting year ahead. Best regards, From The PhorMed Team. https://t.co/OoivsaXzHB

[PhorMed @Phormed1]

#Cancer #cancerday

[PhorMed @Phormed1]

Exciting news: PhorMed reaches $2million raised milestone
With your continued support we can bring our exciting GENOMIC REPAIR TECHNOLOGY to those who need it.
Invest at https://t.co/OoivsaXzHB to help modernize medicine.
Thank you to our investors from The PhorMed family

[PhorMed @Phormed1]

Best Wishes for 2022

[PhorMed @Phormed1]

Happy Holidays and sincere thanks to all our Investors and Followers from the PhorMed team.

[PhorMed @Phormed1]

PhorMed has already raised over $1.8 Million on StartEngine. Join the 3,000+ Investors today at https://t.co/OoivsaXzHB

[PhorMed @Phormed1]

Platform Technology Defined
The ability of our single compound, RP-323, to treat multiple diseases is the reason for its classification as a Platform Technology, which allows us to expand our pipeline without the need of new drug discoveries. Visit the link below for more detail.

[PhorMed @Phormed1]

PhorMed is utilizing it’s platform technology and gene repair therapy to develop a treatment for for those patients who suffer from inflammatory symptoms as a result of the COVID-19 infection. For more information on our drug and how to become an investor, please visit our webpag

[PhorMed @Phormed1]

PhorMed's drug, RP-323, is a gene repair therapy that has the ability to repair damaged or mutated cells. Please visit https://t.co/OoivsaXzHB to view our updated page and videos

[PhorMed @Phormed1]

PhorMed Inc has announced an exciting new collaboration with EMORY University related to Parkinson's disease and a new collaboration agreement with Absorption Systems, related to research in the COVID-19 and Parkinson’s disease areas. Please visit our webpage at StartEngine.

[PhorMed @Phormed1]

PhorMed Inc has announced a new collaboration agreement with Absorption Systems, related to research in the COVID-19 and Parkinson’s disease areas.
Please visit our webpage at https://t.co/OoivsaXzHB and scroll down to the Update section for more information
#COVID19 #Parkinsons

[PhorMed @Phormed1]

PhorMed Inc has announced an exciting new collaboration with EMORY University related to Parkinson's disease. Please visit our webpage at https://t.co/OoivsaXzHB and scroll down to the Update section for more information
#Parkinsons